Russ.Chem.Bull., Int.Ed., Vol. 57, No. 1, January, 2008
145
Syntheses based on anabasine
(1.05 g, 5 mmol) in Et2O (6.5 mL). The reaction mixture was stirred
at ~20 °C for 8.5 h. The precipitate was filtered off and washed with
Et2O. Compound 5 was obtained in a yield of 2.00 g (97%), m.p.
78–81 °C (diethyl ether (DEE)). 1H NMR (CDCl3), δ: 1.32—1.42
(m, 2 H, H(5´), H(5´)); 1.54—1.58 (m, 2H, H(4´), H(4´)); 1.73—
2 H, 2 H(5´)); 1.58—1.76 (m, 2 H, 2 H(4´)); 1.80—1.98 (m, 1 H,
H(3´)); 2.20 (s, 3 H, Me); 2.39 (d, 1 H, H(3´), Jgem = 13.7 Hz); 3.05
(t, 1 H, H(6´), Jgem = 13.2 Hz); 3.71 (d, 1 H, H(6´), Jgem = 13.2 Hz);
3.78 (s, 3 H, Me); 5.94 (s, 1 H, H(2´)); 6.86 (d, 2 H, H(3″), H(5″),
J = 8.9 Hz); 7.10 (q, 2 H, CH2, Jgem = 13.9 Hz); 7.96 (t, 1 H, H(5),
J1 = 6.7 Hz, J2 = 7.6 Hz); 8.03 (d, 2 H, H(2″), H(6″), J = 8.9 Hz);
8.24 (d, 1 H, H(4), J = 7.6 Hz); 9.12 (d, 1 H, H(6), J = 6.7 Hz); 9.22
(s, 1 H, H(2)). 13C NMR (CDCl3), δ: 19.06 (C(4´)); 21.89 (Me);
25.06 (C(5´)); 26.76 (C(3´)); 43.23 (C(6´)); 49.03 (C(2´)); 55.58
(Me); 66.24 (CH2); 114.26 (C(3″)); 114.26 (C(5″)); 126.08 (C(1″));
126.99 (C(5)); 131.19 (C(6″)); 131.26 (C(2″)); 141.42 (C(3)); 144.11
(C(4)); 144.74 (C(6)); 145.03 (C(2)); 164.65 (C(4″)); 170.71 (C=O);
188.22 (C=O). Found (%): C, 49.14; H, 5.46; N, 5.60; Br, 31.48.
C21H25N2O3Br•HBr. Calculated (%): C, 49.03; H, 5.06; N, 5.45;
Br, 31.13.
3ꢀ(1ꢀBenzoylpiperidinꢀ2ꢀyl)ꢀ1ꢀ(4ꢀmethoxyphenacyl)pyridiꢀ
nium bromide hemihydrate (9•0.5 H2O) (96% yield) was synthꢀ
esized from benzoylanabasine 3 according to the aboveꢀdescribed
procedure. M.p. 209—210 °C (DEE). 1H NMR (CDCl3), δ:
1.40—1.64 (m, 3 H, H(4´), 2 H(5´)); 1.65—1.82 (m, 1 H, H(4´));
1.89—2.09 (m, 1 H, H(3´)); 2.58 (d, 1 H, H(3´), Jgem = 13.8 Hz);
2.88 (br.t, 1 H, H(6´)); 3.78 (m, 4 H, Me, H(6´)); 5.92 (br.s, 1 H,
H(2´)); 6.87 (d, 2 H, H(3″), H(5″), J = 8.9 Hz); 7.15 (s, 2 H, CH2);
7.31—7.51 (m, 5 H, H(2″´), H(3″´), H(4″´), H(5″´), H(6″´)); 7.98
(t, 1 H, H(5), J1 = 6.1 Hz, J2 = 6.1 Hz); 8.05 (d, 2 H, H(2″), H(6″),
J = 8.9 Hz); 8.34 (d, 1 H, H(4), J = 6.1 Hz); 9.23 (d, 1 H, H(6), J =
6.1 Hz); 9.34 (s, 1 H, H(2)). 13C NMR (CDCl3), δ: 19.32 (C(4´));
25.18 (C(5´)); 26.87 (C(3´)); 42.56 (C(6´)); 50.61 (C(2´)); 55.54
(Me); 66.27 (CH2); 114.28 (C(3″)); 114.28 (C(5″)); 126.16 (C(1″));
126.64 (C(5)); 127.09 (C(4″´)); 128.45 (C(3″´)); 128.55 (C(5″´));
129.96 (C(6″´)); 130.03 (C(4″)); 131.19 (C(6″)); 131.26 (C(2″));
134.87 (C(1″´)); 140.85 (C(3)); 144.19 (C(4)); 144.89 (C(6)); 145.37
(C(2)); 164.70 (C(4″)); 171.77 (C=O); 188.22 (C=O). Found (%):
C, 61.56; H, 5.58; N, 5.37; Br, 15.61. C26H27N2O3Br•0.5H2O.
Calculated (%): C, 61.90; H, 5.55; N, 5.55; Br, 15.87.
1.87 (m, 1 H, H(3´)); 2.10 (s, 3 H, Me); 2.30 (d, 1 H, H(3´), Jgem
=
12.4 Hz); 2.98 (t, 1 H, H(6´), Jgem = 12.4 Hz); 3.68 (d, 1 H, H(6´),
Jgem = 12.4 Hz); 5.81 (s, 1 H, H(2´)); 7.00 (q, 2 H, CH2, Jgem = 14.8
Hz); 7.33 (t, 2 H, Ph, H(3″), H(5″), J = 7.6 Hz); 7.47 (t, 1 H, Ph,
H(4″), J = 7.6 Hz); 7.92 (dd, 1 H, H(5), J1 = 5.2 Hz, J2 = 8.0 Hz);
7.96 (d, 2 H, Ph, H(2″), H(6″), J = 7.6 Hz); 8.22 (d, 1 H, H(4), J =
8.0 Hz); 9.07 (d, 1 H, H(6), J = 5.2 Hz); 9.15 (s, 1 H, H(2)).
13C NMR (CDCl3), δ: 18.82 (C(4´)); 21.75 (Me); 24.79 (C(5´));
26.75 (C(3´)); 43.04 (C(6´)); 48.95 (C(2´)); 66.44 (CH2); 127.20
(C(5)); 128.51 (C(3″), C(5″)); 128.76 (C(2″), C(6″)); 133.08 (C(1″));
134.44 (C(4″)); 141.14 (C(3)); 144.11 (C(4)); 144.57 (C(2)); 144.63
(C(6)); 170.66 (C=O); 190.06 (C=O). IR (KBr), ν/cm–1: 1696.8
(C=O), 1632.9 (N—(C=O)). Found (%): C, 59.85; H, 5.80; N,
6.66; Br, 19.40. C20H23N2O2Br. Calculated (%): C, 59.54; H,
5.70; N, 6.94; Br, 19.85.
3ꢀ(1ꢀBenzoylpiperidinꢀ2ꢀyl)ꢀ1ꢀphenacylpyridinium bromide
(6) (79% yield) was synthesized from benzoylanabasine 3 accordꢀ
ing to the aboveꢀdescribed procedure. M.p. 108–110 °C (DEE).
1H NMR (CDCl3), δ: 1.30—1.72 (m, 4 H, 2 H(4´), 2 H(5´)); 1.76—
1.95 (m, 1 H, H(3´)); 2.39—2.55 (m, 1 H, H(3´)); 2.65—2.91 (m,
1 H, H(6´)); 3.53—3.87 (m, 1 H, H(6´)); 5.78 (br.s, 1 H, H(2´));
7.04 (s, 2 H, CH2); 7.25—7.52 (m, 8 H, Ph); 7.91—8.02 (m, 3 H,
Ph, H(5)); 8.29 (d, 1 H, H(4), J = 8.0 Hz); 9.21 (d, 1 H, H(6), J =
5.4 Hz); 9.34 (s, 1 H, H(2)). 13C NMR (CDCl3), δ: 19.14 (C(4´));
25.08 (C(5´)); 26.66 (C(3´)); 44.10 (C(6´)); 49.79 (C(2´)); 66.45
(CH2); 126.57 (C(5)); 127.24 (C(4″´)); 128.45 (C(3″´), C(5″´));
128.55 (C(3″), C(5″)); 128.78 (C(2″), C(6″)); 129.93 (C(2″´), C(6″´));
133.08 (C(1″)); 134.48 (C(4″)); 134.64 (C(1″´)); 140.53 (C(3));
144.10 (C(4)); 144.76 (C(6)); 145.06 (C(2)); 171.59 (C=O); 190.04
(C=O). IR (KBr), ν/cm–1: 1696.5 (C=O), 1626.4 (N—(C=O)).
Found (%): C, 64.32; H, 5.43; N, 6.05; Br, 17.19. C25H25N2O2Br.
Calculated (%): C, 64.50; H, 5.37; N, 6.02; Br, 17.20.
3ꢀ(1ꢀMethylpiperidinꢀ2ꢀyl)ꢀNꢀphenacylpyridinium bromide
(7) (59% yield) was synthesized from methylanabasine 4 according
to the aboveꢀdescribed procedure. M.p. 197—197.5 °C (ethanol).
1H NMR ((CD)3SO), δ: 1.24—1.52 (m, 2 H, H(5´), H(5´)); 1.53—
1.72 (m, 2 H, H(4´), H(4´)); 1.79—1.92 (m, 1 H, H(3´)); 2.40 (d,
1 H, H(3´), Jgem = 14 Hz); 3.06 (t, 1 H, H(6´), Jgem = 14 Hz); 3.29 (s,
3 H, Me); 3.68 (d, 1 H, H(6´), Jgem = 14 Hz); 5.68 (br.s, 1 H, H(2´));
6.51 (s, 2 H, CH2); 7.63 (t, 2 H, Ph, H(3″), H(5″), J = 7.7 Hz); 7.77
(t, 1 H, Ph, H(4″), J = 7.4 Hz); 8.05 (d, 2 H, Ph, H(2″), H(6″), J =
7.4 Hz); 8.25 (dd, 1 H, H(5), J1 = 8.2 Hz, J2 = 7.9 Hz); 8.59 (d, 1 H,
H(4), J = 8.2 Hz); 8.92 (d, 1 H, H(6), J = 7.9 Hz); 8.94 (s, 1 H,
H(2)). 13C NMR ((CD)3SO), δ: 19.79 (C(4´)); 24.92 (C(5´)); 27.41
(C(3´)); 42.94 (C(6´)); 47.96 (Me); 54.21 (C(2´)); 66.92 (CH2);
128.15 (C(5)); 128.76 (C(3″), C(5″)); 129.56 (C(2″), C(6″)); 134.16
(C(1″)); 135.17 (C(4″)); 140.36 (C(3)); 145.25 (C(4)); 163.09 (C(6));
163.58 (C(2)); 191.03 (C=O). IR (KBr), ν/cm–1: 1691.6 (C=O),
1660.0 (N—(C=O)). Found (%): C, 61.03; H, 6.27; N, 7.25; Br,
21.17. C19H23N2OBr. Calculated (%): C, 60.80; H, 6.13; N, 7.46;
Br, 21.33.
3ꢀ(1ꢀAcetylpiperidinꢀ2ꢀyl)ꢀ1ꢀmethylpyridinium bromide
(10). A. Potassium carbonate (0.4 g) was added with stirring to a
solution of salt 5 (0.70 g, 1.7 mmol) in ethanol (8 mL). The reaction
mixture was stirred at ~20 °C for 6 h. Then the precipitate was
filtered off, and the mother liquor was concentrated. Benzaldehyde
(0.04 g) (chloroform as the eluent), acetylanabasine (0.18 g, 52%)
(chloroform—ethanol, 100 : 5, as the eluent), and 3ꢀ(1ꢀacetylpiꢀ
peridinꢀ2ꢀyl)ꢀ1ꢀmethylpyridinium bromide (10) (0.22 g, 42%)
(chloroform—ethanol, 10 : 1, as the eluent) were successively isoꢀ
lated from the residue by column chromatography.
B. Triethylamine (2.09 g, 20.7 mmol) was added with stirring to
a solution of salt 5 (0.70 g, 1.7 mmol) in 1,2ꢀdichloroethane
(15 mL), and the reaction mixture was allowed to stand overnight
for 16 h. The precipitate was filtered off, and the mother liquor was
concentrated. Benzaldehyde (0.18 g), acetylanabasine (0.20 g, 57%),
and 3ꢀ(1ꢀacetylpiperidinꢀ2ꢀyl)ꢀ1ꢀmethylpyridinium bromide (10)
(0.12 g, 23% yield) were successively isolated from the residue by
1
column chromatography. H NMR (CDCl3), δ: 1.36—1.52 (m,
2 H, H(5´), H(5´)); 1.69 (d, 2 H, H(4´), H(4´), J = 8 Hz); 1.79—
1.91 (m, 1 H, H(3´)); 2.14 (s, 3 H, Me); 2.36 (d, 1 H, H(3´), Jgem
=
12.4 Hz); 3.11 (t, 1 H, H(6´), Jgem = 11.2 Hz); 3.68 (d, 1 H, H(6´),
Jgem = 11.2 Hz); 4.64 (s, 3 H, Me); 5.79 (s, 1 H, H(2´)); 7.96—8.03
(m, 1 H, H(5)); 8.20 (d, 1 H, H(4), J = 6.8 Hz); 9.14 (s, 1 H, H(6),
J = 5.4 Hz); 9.19 (s, 1 H, H(2)). 13C NMR (CDCl3), δ: 18.84
(C(4´)); 21.75 (Me); 24.60 (C(5´)); 26.82 (C(3´)); 43.13 (C(6´));
48.85 (C(2´)); 49.13 (Me); 127.73 (C(5)); 141.90 (C(3)); 143.18
3ꢀ(1ꢀAcetylpiperidinꢀ2ꢀyl)ꢀ1ꢀ(4ꢀmethoxyphenacyl)pyridiꢀ
nium bromide hydrobromide (8•HBr) (91% yield) was synthesized
according to the aboveꢀdescribed procedure by the reaction of
acetylanabasine 2 with 4ꢀmethoxyphenacylpyridinium bromide.
M.p. 105—109 °C (DEE). 1H NMR (CDCl3), δ: 1.36—1.55 (m,